Full name
BIOFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
10.86.Z - Production of homogenized food products and diet food
20.42.Z - Manufacture of cosmetics and toilet preparations
20.59.Z - Manufacture of other chemical products, not elsewhere classified
21.10.Z - Manufacture of basic pharmaceutical products
46.46.Z - Wholesale trade of pharmaceutical and medical products
47.73.Z - Retail sale of pharmaceutical products
47.91.Z - Intermediary retail sale, non-specialized
55.10.Z - Hotels and similar accommodation establishments
72.1 - Scientific research and development in natural and technical sciences
2019 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 228,7 | 306,1 | 362,4 | 18,4 |
Gross profit (loss) | 66,6 | 72,7 | 127 | 74,6 |
Net profit (loss) | 53,6 | 58,2 | 102,1 | 75,5 |
Cash | 60,6 | 36,6 | 106,9 | 192,1 |
Net income from sale | 324,9 | 417,5 | 476,3 | 14,1 |
Liabilities and provisions for liabilities | 52,2 | 100,2 | 69,5 | -30,7 |
Short time liabilities | 45,7 | 91,2 | 54,4 | -40,3 |
Equity capital | 176,5 | 205,8 | 292,9 | 42,3 |
Working assets | 192,1 | 256,1 | 303,2 | 18,4 |
Operating profit (EBIT) | 66,3 | 71,5 | 128,5 | 79,7 |
% | % | % | p.p. | |
Equity capital to total assets | 77,2 | 67,2 | 80,8 | 13,6 |
Gross profit margin | 20,5 | 17,4 | 26,7 | 9,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 51 | 80 | 42 | -38 |
Current financial liquidity indicator | 3.9880919456481934 | 2.6675961017608643 | 4.8959150314331055 | 2,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane